首页> 美国卫生研究院文献>Eplasty >A Biodegradable Polyurethane Dermal Matrix in Reconstruction of Free Flap Donor Sites: A Pilot Study
【2h】

A Biodegradable Polyurethane Dermal Matrix in Reconstruction of Free Flap Donor Sites: A Pilot Study

机译:一种可生物降解的聚氨酯真皮基质在游离皮瓣供体部位的重建中的初步研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We have developed a biodegradable temporizing matrix (BTM) capable of supporting secondary split-skin graft-take in animal studies. We report its first long-term implantation and use as a dermal scaffold in humans. This preliminary study assesses its ability to integrate, its ease of delamination, its ability to sustain split-skin graft in complex wounds, the degree of wound contraction, and ultimately the quality of the scar at 1 year postimplantation. Ten patients were recruited, each requiring elective free flap reconstruction. Free flap donor sites created were anterolateral thigh flaps, fibular osseocutaneous flaps, or radial/ulnar forearm (RF/UF) flaps. The BTM was implanted when the flap was detached from its donor site. Dressing changes were performed twice weekly. The time elapsed between implantation and delamination depended on the type of flap and thus the wound bed left. Once integrated, the BTMs were delaminated in theatre, and the surface of the “neodermis” was refreshed by dermabrasion, prior to application of a split-skin graft. The BTM integration occurred in all patients (100% in 6 patients, with 90%, 84%, 76%, and 60% integration in the remainder). Integrated BTM sustained successful graft-take in all patients. Complete take was marred in 2 patients, over areas of BTM that had not integrated and graft application was performed too early. The BTM can be applied into wounds in humans and can integrate, persist in the presence of infection, and sustain split-skin overgrafting, despite the trial group presenting with significant comorbidities.
机译:我们已经开发出一种可生物降解的调温基质(BTM),该基质能够支持动物研究中的次生裂口皮肤移植。我们报告了它的第一个长期植入,并在人类中用作真皮支架。这项初步研究评估了其整合能力,脱层的难易程度,在复杂伤口中维持劈裂皮肤移植的能力,伤口的收缩程度以及最终在植入后一年的疤痕质量。招募了10位患者,每位患者都需要进行选择性游离皮瓣重建。创建的游离皮瓣供体部位是大腿前外侧皮瓣,腓骨骨皮瓣或radial /尺前臂(RF / UF)皮瓣。当皮瓣从其供体部位分离时,植入了BTM。每周两次换药。植入和脱层之间经过的时间取决于瓣的类型,因此取决于伤口床。整合后,BTM在剧院内分层,并在应用剖层皮移植物之前通过皮磨术使“新皮层”的表面焕然一新。 BTM整合发生在所有患者中(6例患者中100%整合,其余90%,84%,76%和60%整合)。集成的BTM可以在所有患者中持续成功地进行移植。在尚未整合的BTM区域,有2例患者完全摄取了损害,并且过早进行了移植手术。尽管试验组存在明显的合并症,但BTM仍可以应用于人类伤口,并且可以整合,在感染时持续存在并维持皮肤分裂过度移植。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号